-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on Pharvaris, Raises Price Target to $75

Benzinga·08/13/2026 13:50:51
Listen to the news
Citizens analyst Jonathan Wolleben maintains Pharvaris (NASDAQ:PHVS) with a Market Outperform and raises the price target from $74 to $75.